Univest
Univest
  • Markets
  • 3 Branded Generics, Fermentation-Based Ingredients and Latin America Generics Stocks With a Strong Future Roadmap: Emcure Pharmaceuticals, Concord Biotech and Caplin Point Laboratories

    • October 22, 2026
    • Posted by: Ankit Jaiswal
    • Category: Best Stocks
    No Comments
    3 Branded Generics, Fermentation-Based Ingredients and Latin America Generics Stocks With a Strong Future Roadmap: Emcure Pharmaceuticals, Concord Biotech and Caplin Point Laboratories

    Branded Generic and Ingredient Stocks with a strong future roadmap: Emcure Pharmaceuticals, Concord Biotech and Caplin Point Laboratories. Compare price, valuation, return on equity and revenue growth as of 21 October 2026.

    read more
  • 3 Latin America Generics, Custom Synthesis Ingredients and Finished Dosages Stocks With a Strong Future Roadmap: Caplin Point Laboratories, Divi’s Laboratories and Granules India

    • October 22, 2026
    • Posted by: Lakshit Sharma
    • Category: Best Stocks
    No Comments
    3 Latin America Generics, Custom Synthesis Ingredients and Finished Dosages Stocks With a Strong Future Roadmap: Caplin Point Laboratories, Divi's Laboratories and Granules India

    Emerging Market and API Pharma Stocks with a strong future roadmap: Caplin Point Laboratories, Divi’s Laboratories and Granules India. Compare price, valuation, return on equity and revenue growth as of 21 October 2026.

    read more
  • 3 Domestic Brand Leader, Latin America Generics and Process Chemistry Stocks With a Strong Future Roadmap: Mankind Pharma, Caplin Point Laboratories and Neuland Laboratories

    • October 21, 2026
    • Posted by: Lakshit Sharma
    • Category: Best Stocks
    No Comments
    3 Domestic Brand Leader, Latin America Generics and Process Chemistry Stocks With a Strong Future Roadmap: Mankind Pharma, Caplin Point Laboratories and Neuland Laboratories

    Domestic and Export Pharma Stocks with a strong future roadmap: Mankind Pharma, Caplin Point Laboratories and Neuland Laboratories. Compare price, valuation, return on equity and revenue growth as of 20 October 2026.

    read more
  • 3 Injectable and Contract Formulation Stocks With a Strong Future Roadmap: Caplin Point Laboratories, Venus Remedies and Syncom Formulations (India)

    • October 7, 2026
    • Posted by: Harsh Piplani
    • Category: Best Stocks
    No Comments
    3 Injectable and Contract Formulation Stocks With a Strong Future Roadmap: Caplin Point Laboratories, Venus Remedies and Syncom Formulations (India)

    Caplin Point Laboratories, Venus Remedies and Syncom Formulations (India) compared on growth, margins, debt and valuation, with the roadmap and risks investors should track.

    read more
  • 1
  • 2